Loading resource…

University of California, Davis; University of Utah; The Children's Hospital of Philadelphia
The review provides a comprehensive overview of the unique challenges and regulatory requirements associated with clinical research in special populations. It emphasizes the importance of understanding the vulnerabilities of these groups to ensure their protection during research. The document discusses specific regulations outlined in the Code of Federal Regulations and highlights the need for inclusive practices in clinical trials to enhance representation and safety.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

CLINICAL IMPACT OF ADJUSTED VALPROIC ACID LEVEL IN PATIENTS WITH HYPOALBUMINEMIA
Same clinical topic · Clinical Pharmacology

ADVERSE EVENTS ASSOCIATED WITH FLUMAZENIL TREATMENT FOR THE MANAGEMENT OF SUSPECTED BENZODIAZEPINE INTOXICATION – A SYSTEMATIC REVIEW WITH META-ANALYSES OF RANDOMISED TRIALS
Same clinical topic · Clinical Pharmacology

Traumatic Brain Injury
Same resource type · Neurology

ADA Consensus Report: MASLD in People With Diabetes
Same resource type · Endocrinology

Hospital Care for Children Guidelines
Same resource type · Pediatrics

Management of Obesity
Same resource type

Classification of the Epilepsies
Same resource type · Neurology

AOGU Position Statement on Acetaminophen Use in Pregnancy
Same resource type · Obstetrics and Gynecology

2025 ADA Diabetes Care Standards Updates
Same resource type · Endocrinology